{
  "Variants Include": [
    {
      "Gene": "PARK2",
      "variants": [
        {
          "HGVS": "NM_000302.3:c.830G>A",
          "cDNA Change": {
            "transcript": "NM_000302.3",
            "ref": "G",
            "alt": "A",
            "position": "830"
          },
          "Protein Change": {
            "ref": "G",
            "alt": "D",
            "position": "277"
          },
          "Description in input context": "c.830G>A (p.G277D)"
        },
        {
          "HGVS": "NM_000302.3:c.919G>A",
          "cDNA Change": {
            "transcript": "NM_000302.3",
            "ref": "G",
            "alt": "A",
            "position": "919"
          },
          "Protein Change": {
            "ref": "G",
            "alt": "D",
            "position": "307"
          },
          "Description in input context": "c.919G>A (p.G307D)"
        },
        {
          "HGVS": "NM_000302.3:c.1135G>A",
          "cDNA Change": {
            "transcript": "NM_000302.3",
            "ref": "G",
            "alt": "A",
            "position": "1135"
          },
          "Protein Change": {
            "ref": "G",
            "alt": "D",
            "position": "379"
          },
          "Description in input context": "c.1135G>A (p.G379D)"
        },
        {
          "HGVS": "NM_000302.3:c.1261G>A",
          "cDNA Change": {
            "transcript": "NM_000302.3",
            "ref": "G",
            "alt": "A",
            "position": "1261"
          },
          "Protein Change": {
            "ref": "G",
            "alt": "D",
            "position": "421"
          },
          "Description in input context": "c.1261G>A (p.G421D)"
        },
        {
          "HGVS": "NM_000302.3:c.1304G>A",
          "cDNA Change": {
            "transcript": "NM_000302.3",
            "ref": "G",
            "alt": "A",
            "position": "1304"
          },
          "Protein Change": {
            "ref": "G",
            "alt": "D",
            "position": "435"
          },
          "Description in input context": "c.1304G>A (p.G435D)"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Parkinson's disease",
    "MONDO": "MONDO:0005225"
  },
  "Experiment Method": [
    {
      "Assay Method": "Western Blot",
      "Material used": {
        "Material Source": "Cell line",
        "Material Name": "HEK293",
        "Description": "The experiment was conducted using the HEK293 cell line."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_000302.3:c.830G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "partial loss-of-function",
          "Result Description": "Reduced ubiquitination of the mutant protein compared to wild-type."
        },
        {
          "Variant": "NM_000302.3:c.919G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "partial loss-of-function",
          "Result Description": "Altered protein stability with decreased half-life."
        },
        {
          "Variant": "NM_000302.3:c.1135G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "partial loss-of-function",
          "Result Description": "Reduced mitochondrial complex I activity in transfected cells."
        },
        {
          "Variant": "NM_000302.3:c.1261G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "partial loss-of-function",
          "Result Description": "Impaired ubiquitin ligase activity in vitro."
        },
        {
          "Variant": "NM_000302.3:c.1304G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "partial loss-of-function",
          "Result Description": "Reduced interaction with parkin binding partners."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Experiments were repeated in triplicate across independent cell passages."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Each blot was run in triplicate with independent protein extractions."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type PARK2 cDNA was used as a positive control."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Empty vector transfection was used as a negative control."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "Yes",
        "Counts": "3"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "Yes",
        "Counts": "2"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "ANOVA and Student's t-test were used for statistical analysis."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Ubiquitination levels ≥ 80% of wild-type control",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Ubiquitination levels < 60% of wild-type control",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes",
        "Rationale": "Western blot and immunoprecipitation are standard methods for assessing protein function and interactions in Parkinson's disease research."
      }
    },
    {
      "Assay Method": "Immunoprecipitation",
      "Material used": {
        "Material Source": "Cell line",
        "Material Name": "SH-SY5Y",
        "Description": "The experiment was conducted using the SH-SY5Y cell line."
      },
      "Readout type": "Qualitative",
      "Readout description": [
        {
          "Variant": "NM_000302.3:c.830G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "partial loss-of-function",
          "Result Description": "Reduced co-immunoprecipitation with ubiquitin and parkin binding partners."
        },
        {
          "Variant": "NM_000302.3:c.919G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "partial loss-of-function",
          "Result Description": "Altered interaction with mitochondrial proteins."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Experiments were repeated in duplicate across independent cell passages."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Each immunoprecipitation was performed in triplicate."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type PARK2 cDNA was used as a positive control."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "IgG control was used as a negative control."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "Yes",
        "Counts": "2"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "Yes",
        "Counts": "1"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "Student's t-test was used for statistical analysis."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Co-immunoprecipitation signal ≥ 70% of wild-type control",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Co-immunoprecipitation signal < 50% of wild-type control",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes",
        "Rationale": "Immunoprecipitation is a standard method for assessing protein-protein interactions in Parkinson's disease research."
      }
    }
  ]
}